| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Age-Adjusted Reference Values for Prostate Specific Antigen – A Systematic Review and Meta-Analysis
|
Matti, Bashar
|
|
|
20 |
2 |
p. e114-e125
|
artikel
|
| 2 |
A Serendipitous Preoperative Trial of Combined Ipilimumab Plus Nivolumab for Localized Prostate Cancer
|
van Dorp, Jeroen
|
|
|
20 |
2 |
p. e173-e179
|
artikel
|
| 3 |
Association Between Preoperative De Ritis (AST/ALT) Ratio and Oncological Outcomes Following Radical Cystectomy in Patients With Urothelial Bladder Cancer
|
Ghahari, Mohammadreza
|
|
|
20 |
2 |
p. e89-e93
|
artikel
|
| 4 |
Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary Bladder
|
Kosiba, Marina
|
|
|
20 |
2 |
p. 195.e1-195.e8
|
artikel
|
| 5 |
Contemporary Trends of Systemic Neoadjuvant and Adjuvant Intravesical Chemotherapy in Patients With Upper Tract Urothelial Carcinomas Undergoing Minimally Invasive or Open Radical Nephroureterectomy: Analysis of US Claims on Perioperative Outcomes and Health Care Costs
|
Del Giudice, Francesco
|
|
|
20 |
2 |
p. 198.e1-198.e9
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
20 |
2 |
p. A1
|
artikel
|
| 7 |
Enhanced Bellmunt Risk Score for Survival Prediction in Urothelial Carcinoma Treated With Immunotherapy
|
Abuhelwa, Ahmad Y.
|
|
|
20 |
2 |
p. 132-138
|
artikel
|
| 8 |
Establishing metastatic prostate cancer quality indicators using a modified Delphi approach
|
Zheng, Jia
|
|
|
20 |
2 |
p. e151-e157
|
artikel
|
| 9 |
Evaluation of Patient-Reported Outcomes (PROs) Protocol Content and Reporting for Clinical Trials that Lead to the approval of frontline Immune Checkpoint Blockade Combination for Patients with Advanced Renal Cell Carcinoma - The Patients’ Voice or a Missed Opportunity
|
Chadha, Juskaran
|
|
|
20 |
2 |
p. e158-e165
|
artikel
|
| 10 |
Extreme Responses to a Combination of DNA-Damaging Therapy and Immunotherapy in CDK12-Altered Metastatic Castration-Resistant Prostate Cancer: A Potential Therapeutic Vulnerability
|
Gongora, Aline B.L.
|
|
|
20 |
2 |
p. 183-188
|
artikel
|
| 11 |
Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma
|
Adibi, Mehrad
|
|
|
20 |
2 |
p. 176-182
|
artikel
|
| 12 |
Gender and Age Differences of Genitourinary Cancers Among Chronic Dialysis Patients in Taiwan
|
Tang, Chao‐Hsiun
|
|
|
20 |
2 |
p. e126-e134
|
artikel
|
| 13 |
Helix: A Digital Tool to Address Provider Needs for Prostate Cancer Genetic Testing in Clinical Practice
|
Giri, Veda N.
|
|
|
20 |
2 |
p. e104-e113
|
artikel
|
| 14 |
Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis
|
Ferro, Matteo
|
|
|
20 |
2 |
p. e166-e172
|
artikel
|
| 15 |
Impact of New Systemic Therapies in Overall Survival in Non-Metastatic Castration Resistant Prostate Cancer: Systematic Review and Meta-Analysis
|
Rodriguez-Vida, Alejo
|
|
|
20 |
2 |
p. 197.e1-197.e10
|
artikel
|
| 16 |
Impact of Variant Histology on Occult Nodal Metastasis after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Review of the National Cancer Database
|
Fu, Melinda
|
|
|
20 |
2 |
p. e135-e139
|
artikel
|
| 17 |
Management of Patients With Advanced Urothelial Carcinoma in an Evolving Treatment Landscape: A Qualitative Study of Provider Perspectives of First-Line Therapies
|
Grivas, Petros
|
|
|
20 |
2 |
p. 114-122
|
artikel
|
| 18 |
Molecular and Clinical Characterization of Patients With Metastatic Castration Resistant Prostate Cancer Achieving Deep Responses to Bipolar Androgen Therapy
|
Markowski, Mark C.
|
|
|
20 |
2 |
p. 97-101
|
artikel
|
| 19 |
Neutrophil-to-Lymphocyte Ratio Predicts Cancer Outcome in Locally Advanced Clear Renal Cell Carcinoma
|
Cordeiro, Mauricio Dener
|
|
|
20 |
2 |
p. 102-106
|
artikel
|
| 20 |
Oncologic Outcomes of Squamous Cell Carcinoma Versus Urothelial Carcinoma With Squamous Differentiation After Radical Cystectomy for Bladder Carcinoma
|
Laymon, Mahmoud
|
|
|
20 |
2 |
p. 148-154
|
artikel
|
| 21 |
Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate Cancer
|
Andruska, Neal
|
|
|
20 |
2 |
p. 123-131
|
artikel
|
| 22 |
Repeat Treatment of Patients With Advanced Urothelial Carcinoma With Immune Checkpoint Inhibitors Following Prior Progression on a Checkpoint Inhibitor Regimen: A Case Series
|
Jindal, Tanya
|
|
|
20 |
2 |
p. 189-194
|
artikel
|
| 23 |
Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin
|
Talukder, Rafee
|
|
|
20 |
2 |
p. 165-175
|
artikel
|
| 24 |
Response to Pembrolizumab After Dose-Reduced Cisplatin Plus Gemcitabine Chemotherapy Is Inferior to That After Carboplatin Plus Gemcitabine Chemotherapy in Cisplatin-Unfit Patients With Advanced Urothelial Carcinoma
|
Miyake, Makito
|
|
|
20 |
2 |
p. 196.e1-196.e9
|
artikel
|
| 25 |
Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study
|
Raggi, Daniele
|
|
|
20 |
2 |
p. 155-164
|
artikel
|
| 26 |
Sarcomatoid Urothelial Carcinoma: A Population-Based Study of Clinicopathologic Characteristics and Survival Outcomes
|
Diamantopoulos, Leonidas N.
|
|
|
20 |
2 |
p. 139-147
|
artikel
|
| 27 |
Sociodemographic Disparities in Access to Chemotherapy for Bladder Cancer
|
Venkat, Siv
|
|
|
20 |
2 |
p. e140-e150
|
artikel
|
| 28 |
Table of contents
|
|
|
|
20 |
2 |
p. A3-A7
|
artikel
|
| 29 |
Thoracic Radiotherapy for Renal Cell Carcinoma Metastases: Local Control for the Management of Lung and Mediastinal Disease in the Modern Era
|
Stewart, Glenn A.
|
|
|
20 |
2 |
p. 107-113
|
artikel
|
| 30 |
Trends and Predictors of Hypofractionated and Intensity-Modulated Radiotherapy for Organ Preservation in Bladder Cancer
|
Xiang, Michael
|
|
|
20 |
2 |
p. e94-e103
|
artikel
|
Tijdschrift beschrijving